Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769769 · ClinicalTrials.gov registry record · Phase 3
Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers
A Phase 3 study of Depression, sponsored by Robert L. Glueckauf.
- Completed
- Registry status
- Phase 3
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT00769769: Completed Phase 3 study of Depression, sponsored by Robert L. Glueckauf.
NCT00769769 is a Phase 3 study of Depression that has completed, run by Robert L. Glueckauf. The registered enrollment target is 106 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00769769, a Phase 3 study of Depression, has completed, sponsored by Robert L. Glueckauf.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effectiveness of face-to-face cognitive behavioral therapy versus telephone-based cognitive behavioral therapy for treating African Americans who care for family members with dementia.
Conditions Studied
Interventions
- BEHAVIORAL Psychotherapy
Study Locations (1)
Florida
- Florida State University College of Medicine - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00769769
The ClinicalTrials.gov registry entry for NCT00769769 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Robert L. Glueckauf, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Psychotherapy is the first listed.
NCT00769769 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00769769 about?
NCT00769769 is a clinical study titled "Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers". This study will compare the effectiveness of face-to-face cognitive behavioral therapy versus telephone-based cognitive behavioral therapy for treating African Americans who care for family members with dementia.
What is the current status of trial NCT00769769?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 106 participants. The study started on 2008-10. Estimated completion is 2012-02.
What conditions does trial NCT00769769 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00769769?
The interventions under investigation include: Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00769769?
This trial is sponsored by Robert L. Glueckauf, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00769769 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.